Company Registration No. 13885505 (England and Wales)
Harlon Healthcare Limited
Unaudited accounts
for the period from 1 February 2022 to 28 February 2023
Harlon Healthcare Limited
Unaudited accounts
Contents
Harlon Healthcare Limited
Company Information
for the period from 1 February 2022 to 28 February 2023
Directors
Colin Kasambira
Julian Kasambira
Company Number
13885505 (England and Wales)
Registered Office
27 Old Gloucester Street
London
WC1N 3AX
England
Harlon Healthcare Limited
Statement of financial position
as at 28 February 2023
Cash at bank and in hand
16,079
Creditors: amounts falling due within one year
(118,806)
Net current liabilities
(102,727)
Profit and loss account
(101,244)
Shareholders' funds
(101,242)
For the period ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 3 July 2023 and were signed on its behalf by
Colin Kasambira
Director
Company Registration No. 13885505
Harlon Healthcare Limited
Notes to the Accounts
for the period from 1 February 2022 to 28 February 2023
Harlon Healthcare Limited is a private company, limited by shares, registered in England and Wales, registration number 13885505. The registered office is 27 Old Gloucester Street, London, WC1N 3AX, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the period from 1 February 2022 to 28 February 2023 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 February 2022.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 28 February 2023
787
735
1,522
Charge for the period
22
15
37
At 28 February 2023
22
15
37
At 28 February 2023
765
720
1,485
Harlon Healthcare Limited
Notes to the Accounts
for the period from 1 February 2022 to 28 February 2023
5
Creditors: amounts falling due within one year
2023
Loans from directors
110,473
6
Average number of employees
During the period the average number of employees was 1.